GKSHBO: Adverse Radiation Effects After Gamma Knife Radio Surgery and Hyperbaric Oxygen Therapy

Sponsor
Niguarda Hospital (Other)
Overall Status
Recruiting
CT.gov ID
NCT02714465
Collaborator
(none)
65
1
1
84
0.8

Study Details

Study Description

Brief Summary

Evaluation of clinical improvement and the reduction of edema lesion documented by magnetic resonance imaging (MRI) in patients with cerebral radiation necrosis post gamma knife surgery (GKS) by treatment with hyperbaric oxygen therapy (HBO)

Condition or Disease Intervention/Treatment Phase
  • Other: hyperbaric oxygen therapy
N/A

Detailed Description

Patients will be recruited on the basis of the presence of cerebral radionecrosis post gamma knife surgery, documented by both clinical examination (Rankin Scale) and instrumental imaging (MRI). They will be subjected to hyperbaric oxygen therapy HBO, and during treatment the patient performs clinical examination (Rankin Scale) for 24 sessions of HBO. Then they will have a break of 10-15 days during which also performs the instrumental survey (Magnetic Resonance Imaging). If the radionecrosis has regressed they will suspend the treatment otherwise continue up to a maximum of 40 treatment sessions of HBO

Study Design

Study Type:
Interventional
Anticipated Enrollment :
65 participants
Allocation:
N/A
Intervention Model:
Single Group Assignment
Masking:
None (Open Label)
Primary Purpose:
Treatment
Official Title:
Treatment of Adverse Radiation Effects After Gamma Knife Radiosurgery (GKS) by Hyperbaric Oxygen Therapy (HBO)
Actual Study Start Date :
Mar 1, 2016
Anticipated Primary Completion Date :
Dec 1, 2022
Anticipated Study Completion Date :
Mar 1, 2023

Arms and Interventions

Arm Intervention/Treatment
Experimental: Hyperbaric oxygen therapy

All patients underwent radiosurgery with clinical and instrumental signs of cerebral radionecrosis

Other: hyperbaric oxygen therapy
hyperbaric oxygen therapy

Outcome Measures

Primary Outcome Measures

  1. Evaluation of clinical improvement [day 2 through day 25]

    By neurological evaluation (Ranking Scale)

Secondary Outcome Measures

  1. Evaluation of the reduction of the extent of edema lesion documented by MRI [1-3 months]

    MRI analysis

  2. Measurement of complications from hyperbaric oxygen therapy and their severity [through study completion, an average of 1 year]

Eligibility Criteria

Criteria

Ages Eligible for Study:
10 Years to 75 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • between 10 and 75 years

  • understanding of the Italian language

  • ability to understand the procedures and carrying out of the study

  • signing informed consent for adults and minors in use

  • underwent radiosurgery with clinical and instrumental signs of radiation necrosis

Exclusion Criteria:
  • younger than 10yrs old and older than 75yrs old

  • not capable to understand Italian language or to understand the protocol procedures and visits' scheme

  • informed consent not given

  • enrolled in another clinical trial

  • concomitant pathologies contraindicate HBO as: emphysema, asthma, epilepsy, claustrophobia; Paul Bert Syndrome, Lorrain Smith Syndrome

  • under disulfiram, doxorubicine, cisplatinum, mafenide acetate, bleomycins treatment

  • life expectancy less than 6 months

  • Rankin Scale >5

Contacts and Locations

Locations

Site City State Country Postal Code
1 ASST Grande Ospedale Metropolitano Niguarda Milano Lombardia Italy 20162

Sponsors and Collaborators

  • Niguarda Hospital

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Niguarda Hospital
ClinicalTrials.gov Identifier:
NCT02714465
Other Study ID Numbers:
  • 644-122015
First Posted:
Mar 21, 2016
Last Update Posted:
Apr 8, 2021
Last Verified:
Apr 1, 2021
Keywords provided by Niguarda Hospital
Additional relevant MeSH terms:

Study Results

No Results Posted as of Apr 8, 2021